Senior Primary Care Pharmacist (Governance)

An excellent opportunity has arisen for a dynamic pharmacist to join the Medicines Optimisation Team in Southwark for a secondment or a fixed term contract ending 19 October 2023 In the changing NHS Landscape, the Medicines Optimisation Team is continuously developing collaborative engagement with partners across the borough and wider South East London environment. Through governance, the team promotes the development of safe and effective provider-based medicines optimisation to enable clinically and cost-effective use of medicines for our population. We are an established and inspired team and have a long history of successful working relationships with our local stakeholders. As part of the Medicines Optimisation Team, you will be working closely with GPs and other clinicians to shape healthcare and NHS commissioning locally. Southwark Borough is part of the South East London Integrated Care System and is made up of all GP surgeries in the borough. With a budget of approximately £400 million our job is to make the most effective use of this money to best meet the health needs of people in Southwark. Our main providers are Kings College Hospital NHS Foundation Trust, Guys and St Thomas’ NHS Foundation Trust and South London and the Maudsley NHS Foundation Trust. Our strategic ambition is set out in the NHS Long Term Plan We are a friendly organisation with a thriving health and well-being culture for our staff. We are co-located with Southwark Council in modern offices between London Bridge and Tower Bridge. With excellent interpersonal and communication skills, you will work as part of Southwark’s Medicines Optimisation Team to improve medicines use for the people of Southwark, who have a rich cultural, social, and economic diversity. You will contribute to promoting and implementing medicines optimisation initiatives within primary care, focusing on cost-effective and quality prescribing. You will also support the delivery of a portfolio of national (QIPP) and locally agreed targets relating to Medicines Optimisation.